Ziel
Venomous animals represent a major source of highly selective and efficient bioactive compounds that have already led to the development of several new drugs. The latest FDA approved example is Prialt, a peptide originating from the venom of a cone snail (Conus magus). CONCO is an innovative post-genomic project dedicated to the discovery and development of novel biopharmaceuticals generated by the broad biodiversity of cone snails.
The project aims at characterizing from the genomic up to potential therapeutic properties all the putative bioactive compounds that can be synthesised by a cone snail species. The genome and transcriptome of Conus consors will be exhaustively studied. Large amounts of venom will be fractionated and submitted to proteomic studies to generate a biochemically characterized 'natural library' of compounds. Large-scale synthesis of each identified candidate will be achieved to form a "synthetic library" of compounds.
Wissenschaftliches Gebiet
Programm/Programme
Thema/Themen
Aufforderung zur Vorschlagseinreichung
FP6-2005-LIFESCIHEALTH-6
Andere Projekte für diesen Aufruf anzeigen
Finanzierungsplan
IP - Integrated ProjectKoordinator
PLAN-LES-OUATES - GENEVA
Schweiz
Auf der Karte ansehen
Beteiligte (19)
FRANKFURT AM MAIN
Auf der Karte ansehen
ROCKVILLE, MARYLAND
Auf der Karte ansehen
MONTPELLIER
Auf der Karte ansehen
PARIS
Auf der Karte ansehen
ISSY-LES-MOULINEAUX
Auf der Karte ansehen
1211 Geneva 4 GENEVA
Auf der Karte ansehen